115 related articles for article (PubMed ID: 27659111)
1. Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate.
D'mello SA; Joseph WR; Green TN; Leung EY; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
Cell Calcium; 2016 Dec; 60(6):384-395. PubMed ID: 27659111
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.
Prickett TD; Zerlanko BJ; Hill VK; Gartner JJ; Qutob N; Jiang J; Simaan M; Wunderlich J; Gutkind JS; Rosenberg SA; Samuels Y
J Invest Dermatol; 2014 Sep; 134(9):2390-2398. PubMed ID: 24739903
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Functional Analysis of GRIN2A in Tumor Samples.
Prickett TD; Gartner JJ; Samuels Y
Methods Mol Biol; 2017; 1677():93-116. PubMed ID: 28986867
[TBL] [Abstract][Full Text] [Related]
4. Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
D'mello SA; Flanagan JU; Green TN; Leung EY; Askarian-Amiri ME; Joseph WR; McCrystal MR; Isaacs RJ; Shaw JH; Furneaux CE; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
Front Oncol; 2014 Jan; 3():333. PubMed ID: 24455489
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation.
Kamal T; Green TN; Morel-Kopp MC; Ward CM; McGregor AL; McGlashan SR; Bohlander SK; Browett PJ; Teague L; During MJ; Skerry TM; Josefsson EC; Kalev-Zylinska ML
Cell Signal; 2015 Sep; 27(9):1860-72. PubMed ID: 25982509
[TBL] [Abstract][Full Text] [Related]
6. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
[TBL] [Abstract][Full Text] [Related]
7. A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder.
Fernández-Marmiesse A; Kusumoto H; Rekarte S; Roca I; Zhang J; Myers SJ; Traynelis SF; Couce ML; Gutierrez-Solana L; Yuan H
Mov Disord; 2018 Jul; 33(6):992-999. PubMed ID: 29644724
[TBL] [Abstract][Full Text] [Related]
8. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
[TBL] [Abstract][Full Text] [Related]
9. The excitotoxity of NMDA receptor NR2D subtype mediates human fetal lung fibroblasts proliferation and collagen production.
Wang M; Luo Z; Yue Y; Wang Y; Wu S; Cao C; Liao Z; Yu X; Yue S
Toxicol In Vitro; 2018 Feb; 46():47-57. PubMed ID: 28987794
[TBL] [Abstract][Full Text] [Related]
10. Site within N-Methyl-D-aspartate receptor pore modulates channel gating.
Chen N; Li B; Murphy TH; Raymond LA
Mol Pharmacol; 2004 Jan; 65(1):157-64. PubMed ID: 14722247
[TBL] [Abstract][Full Text] [Related]
11. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations.
Serraz B; Grand T; Paoletti P
Neuropharmacology; 2016 Oct; 109():196-204. PubMed ID: 27288002
[TBL] [Abstract][Full Text] [Related]
12. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
[TBL] [Abstract][Full Text] [Related]
13. Effects of NMDA receptor modulators on a blood-brain barrier in vitro model.
Neuhaus W; Freidl M; Szkokan P; Berger M; Wirth M; Winkler J; Gabor F; Pifl C; Noe CR
Brain Res; 2011 Jun; 1394():49-61. PubMed ID: 21549356
[TBL] [Abstract][Full Text] [Related]
14. Functional Evaluation of a De Novo
Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
[TBL] [Abstract][Full Text] [Related]
15. NMDA receptor modulation of glutamate release in activated neutrophils.
Del Arroyo AG; Hadjihambi A; Sanchez J; Turovsky E; Kasymov V; Cain D; Nightingale TD; Lambden S; Grant SGN; Gourine AV; Ackland GL
EBioMedicine; 2019 Sep; 47():457-469. PubMed ID: 31401196
[TBL] [Abstract][Full Text] [Related]
16. Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region.
Adams J; Crosbie J; Wigg K; Ickowicz A; Pathare T; Roberts W; Malone M; Schachar R; Tannock R; Kennedy JL; Barr CL
Mol Psychiatry; 2004 May; 9(5):494-9. PubMed ID: 14699423
[TBL] [Abstract][Full Text] [Related]
17. A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate.
Yeboah F; Guo H; Bill A
J Vis Exp; 2018 Jul; (137):. PubMed ID: 30059041
[TBL] [Abstract][Full Text] [Related]
18. N-Methyl-D-Aspartate Receptor-Driven Calcium Influx Potentiates the Adverse Effects of Myocardial Ischemia-Reperfusion Injury Ex Vivo.
Liu ZY; Hu S; Zhong QW; Tian CN; Ma HM; Yu JJ
J Cardiovasc Pharmacol; 2017 Nov; 70(5):329-338. PubMed ID: 28777252
[TBL] [Abstract][Full Text] [Related]
19. GRIN2A polymorphisms and expression levels are associated with lead-induced neurotoxicity.
Wu Y; Wang Y; Wang M; Sun N; Li C
Toxicol Ind Health; 2017 Apr; 33(4):332-339. PubMed ID: 27230353
[TBL] [Abstract][Full Text] [Related]
20. Fast interaction between AMPA and NMDA receptors by intracellular calcium.
Rozov A; Burnashev N
Cell Calcium; 2016 Dec; 60(6):407-414. PubMed ID: 27707506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
